Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-02-28
1998-03-31
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514365, 514370, 514377, 514342, 514397, 514398, 514400, 546175, 546278, 548193, 548194, 548200, 548204, 548233, 548236, 5483127, 5483151, 5483285, 5483325, 5483355, 5483381, 5483385, C07D23364, A61K 31415
Patent
active
057338825
ABSTRACT:
The present invention provides compounds, more particularly dipeptide analogs, which bind to retroviral proteases. These compounds are inhibitors of retroviral proteases and are useful for treating diseases related to infection by retroviruses.
REFERENCES:
patent: 4431653 (1984-02-01), Wei et al.
patent: 4661473 (1987-04-01), Boger et al.
patent: 4713445 (1987-12-01), Szelke et al.
patent: 4812442 (1989-03-01), Boger et al.
patent: 5142056 (1992-08-01), Kempe et al.
Young et al., J. Med. Chem., 35, 1992, pp. 1702-1709.
Thaisrivongs et al., J. Med. Chem. 1991, 34 pp. 2344-2356.
deSolms et al., J. Med. Chem., 1991, 34, pp. 2852-2857.
Roberts et al., Science, 248, 1990, pp. 358-361.
Sham et al., J. Chem. Soc., Chem. Commun., 1991, pp. 110-112.
Green, Protective Groups in Org. Sym. pp. 335-338, 366,67 (1991).
Carr Thomas Joseph
DeMarsh Peter Lawrence
Dreyer Geoffrey Bainbridge
Fenwick Ashley Edward
Gerstl Robert
Kinzig Charles M.
Lentz Edward T.
SmithKline Beecham Corporation
LandOfFree
Retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-51976